Showing results (11-20 of 66) with videos related to
Sort By:
Pageof 7
Revue D'Histoire De La Pharmacie|January 1, 1995
[The history of Lipiodol (1901-1994) or How a medication may evolve with the times]B Bonnemain, M GuerbetRevue D'Histoire De La Pharmacie|January 1, 1995
[The discovery of Tenebryl, the first French uro-angiographic iodized hydrosoluble product]B Bonnemain, M GuerbetJournal of Magnetic Resonance Imaging : JMRI|June 18, 1999
Equilibrium phase MR angiography of the aortic arch and abdominal vasculature with the blood pool contrast agent CMD-A2-Gd-DOTA in pigsL J Kroft, J Doornbos, S Benderbous, et al.Investigative Radiology|September 1, 1988
Gd-DOTA, a potential MRI contrast agent. Current status of physicochemical knowledgeD Meyer, M Schaefer, B BonnemainAJNR. American Journal of Neuroradiology|September 1, 1983
Gadolinium as a contrast agent for NMRJ M Caillé, B Lemanceau, B BonnemainInvestigative Radiology|May 1, 1996
Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbitsP Loubeyre, E Canet, S Zhao, et al.Fundamental & Clinical Pharmacology|January 1, 1994
Iodinated contrast media-induced nephropathy: pathophysiology, clinical aspects and preventionJ M Idée, H Beaufils, B BonnemainActa Radiologica (Stockholm, Sweden : 1987)|September 1, 1995
Comparative study of the dialysability of iobitridol and iohexol in the rat with impaired renal functionA Dencausse, C Chambon, X Violas, et al.Journal of Microencapsulation|March 30, 2000
Niosomes as carriers of radiopaque contrast agents for X-ray imagingD Muller, M Foulon, B Bonnemain, et al.Investigative Radiology|January 19, 2000
Pilot MR evaluation of pharmacokinetics and relaxivity of specific blood pool agents for MR angiographyB Marchand, P C Douek, S Benderbous, et al.Pageof 7